Indian pharmaceutical stocks traded mostly lower on May 18 2026 during the morning session. The BSE Healthcare index declined 0.87% to 46,781.22, in line with the broader market weakness. The Nifty 50 was down 1.35% at 23,325.05 and the S&P BSE Sensex fell 1.37% to 74,204.18 as of around 9:54 AM.
Top Gainers in Pharma Sector
- Panacea Biotech was the top performer, rising 3.66% on BSE to ₹401.15 and 3.36% on NSE.
- IPCA Labs gained 0.87% on BSE to ₹1,619.75 and 0.92% on NSE.
- Wockhardt advanced 0.72% on BSE to ₹1,557.10.
- Ajanta Pharma rose 0.46–0.52%.
Major Losers in Pharma Sector
- Alembic Pharma witnessed the sharpest decline, falling 8.19% on BSE to ₹720.45 and 8.32% on NSE.
- Indoco Remedies dropped 3.33–3.61%.
- Natco Pharma declined 2.30–2.48%.
- Aarti Drugs was down 2.11–2.27%.
- Strides Pharma Science fell 2.14–2.25%.
Other stocks trading lower included Lupin, Torrent Pharma, Zydus Lifesciences, J.B. Chemicals, Biocon, Sun Pharma, Divis Laboratories, Mankind Pharma, and Sudeep Pharma.
Most other pharma stocks, including Cipla, Aurobindo Pharma, Dr. Reddy’s Lab, and Glenmark Pharma, also saw mild to moderate declines.
Note: All prices and percentage changes are based on data as of 9:54 AM on BSE and NSE on May 18 2026. Market prices are volatile and continue to change rapidly. This is for informational purposes only and does not constitute investment advice. For the latest live prices, please check the official NSE and BSE websites.